Stockscreener 앱 받기
2.58
0.39%
0.01
시간 외 거래:
2.60
0.02
+0.78%
전일 마감가:
$2.57
열려 있는:
$2.56
하루 거래량:
402.86K
Relative Volume:
0.28
시가총액:
$183.62M
수익:
$20.76M
순이익/손실:
$-132.49M
주가수익비율:
-0.9663
EPS:
-2.67
순현금흐름:
$-108.55M
1주 성능:
-0.77%
1개월 성능:
+14.16%
6개월 성능:
-0.77%
1년 성능:
-59.88%
1일 변동 폭
$2.525
$2.61
1주일 범위
$2.45
$2.755
52주 변동 폭
$1.085
$7.22
C 4 Therapeutics Inc Stock (CCCC) Company Profile
명칭
C 4 Therapeutics Inc
전화
(617) 231-0700
주소
490 ARSENAL WAY, WATERTOWN
CCCC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CCCC
C 4 Therapeutics Inc
|
2.58 | 182.91M | 20.76M | -132.49M | -108.55M | -2.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
C 4 Therapeutics Inc Stock (CCCC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-11-18 | 개시 | Stephens | Equal-Weight |
| 2024-01-29 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2023-12-13 | 업그레이드 | Stifel | Hold → Buy |
| 2023-02-24 | 업그레이드 | Credit Suisse | Underperform → Neutral |
| 2023-02-24 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2022-11-04 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-10-11 | 개시 | Morgan Stanley | Underweight |
| 2022-04-28 | 개시 | Credit Suisse | Underperform |
| 2022-04-11 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-03-10 | 개시 | JP Morgan | Overweight |
| 2022-02-11 | 재개 | BMO Capital Markets | Outperform |
| 2022-02-10 | 개시 | Wells Fargo | Equal Weight |
| 2021-11-23 | 개시 | BofA Securities | Buy |
| 2021-10-14 | 개시 | SVB Leerink | Mkt Perform |
| 2021-09-30 | 개시 | Stifel | Hold |
| 2021-06-04 | 개시 | H.C. Wainwright | Buy |
| 2021-03-31 | 개시 | BMO Capital Markets | Outperform |
| 2020-10-28 | 개시 | UBS | Buy |
| 2020-10-27 | 개시 | BMO Capital Markets | Outperform |
| 2020-10-27 | 개시 | Jefferies | Buy |
모두보기
C 4 Therapeutics Inc 주식(CCCC)의 최신 뉴스
How to integrate C4 Therapeutics Inc. into portfolio analysis toolsM&A Rumor & AI Optimized Trade Strategies - Newser
Does C4 Therapeutics Inc. show high probability of reboundJuly 2025 Update & Technical Pattern Alert System - Newser
Technical signs of recovery in C4 Therapeutics IncJuly 2025 PostEarnings & Verified Chart Pattern Signals - Newser
Visual trend scoring systems applied to C4 Therapeutics Inc.2025 Big Picture & Long-Term Capital Growth Ideas - Newser
Will C4 Therapeutics Inc. see short term momentumTrade Ideas & Weekly Hot Stock Watchlists - Newser
How hedge fund analytics apply to C4 Therapeutics Inc. stockJuly 2025 Technicals & AI Powered Buy/Sell Recommendations - Newser
Technical signs of recovery in C4 Therapeutics Inc.July 2025 Outlook & Free Technical Pattern Based Buy Signals - Newser
Can swing trading help recover from C4 Therapeutics Inc. lossesStop Loss & Stepwise Trade Signal Implementation - Newser
Detecting support and resistance levels for C4 Therapeutics Inc.Price Action & Daily Oversold Stock Bounce Ideas - Newser
Market reaction to C4 Therapeutics Inc.’s recent newsJuly 2025 Reactions & Capital Efficient Trading Techniques - Newser
Using Bollinger Bands to evaluate C4 Therapeutics Inc.2025 Buyback Activity & Expert Verified Stock Movement Alerts - Newser
Is C4 Therapeutics Inc. forming a reversal patternM&A Rumor & AI Based Trade Execution Alerts - Newser
Screener Results Flag C4 Therapeutics Inc. as OversoldJuly 2025 Analyst Calls & Daily Risk Controlled Trade Plans - newsyoung.net
Using Bollinger Bands to evaluate C4 Therapeutics Inc2025 Geopolitical Influence & Fast Entry Momentum Alerts - Newser
Should I hold or sell C4 Therapeutics Inc. nowMarket Rally & Scalable Portfolio Growth Ideas - theviewers.co.kr
Death Cross: What is the dividend yield of C4 Therapeutics Inc.2025 Price Targets & Verified Technical Trade Signals - theviewers.co.kr
How does C4 Therapeutics Inc. compare to its peers2025 Key Lessons & Growth Oriented Trading Recommendations - theviewers.co.kr
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
C4 Therapeutics Inc. Bounces Off Moving Average Support2025 Historical Comparison & Safe Capital Growth Plans - 더경남뉴스
What makes C4 Therapeutics Inc. stock price move sharply2025 Breakouts & Breakdowns & Free Reliable Trade Execution Plans - Newser
How to manage a losing position in C4 Therapeutics Inc.Swing Trade & Weekly Top Performers Watchlists - Newser
What analysts say about C4 Therapeutics Inc. stock outlookWeekly Volume Report & Free AI Powered Buy and Sell Recommendations - Newser
Stoke Therapeutics announces inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Business Wire
Real time breakdown of C4 Therapeutics Inc. stock performanceJuly 2025 Decliners & Fast Exit Strategy with Risk Control - Newser
What the charts say about C4 Therapeutics Inc. todayWeekly Loss Report & Reliable Price Breakout Alerts - Newser
C4 Therapeutics Inc. Breakout Confirmed by Volume MetricsVolume Spike & Entry Point Confirmation Signals - beatles.ru
Is C4 Therapeutics Inc. stock ready for a breakout2025 Trading Volume Trends & Expert Approved Momentum Trade Ideas - Newser
Long term hold vs stop loss in C4 Therapeutics Inc.July 2025 Update & Short-Term Swing Trade Alerts - Newser
Understanding C4 Therapeutics Inc.’s price movementWeekly Earnings Recap & Safe Entry Point Identification - Newser
What is the dividend yield of C4 Therapeutics Inc.Quarterly Portfolio Review & Free Fast Gain Swing Trade Alerts - thegnnews.com
XTX Topco Ltd Makes New Investment in C4 Therapeutics, Inc. (NASDAQ:CCCC) - Defense World
How institutional ownership impacts C4 Therapeutics Inc. stock2025 Trading Recap & Risk Controlled Stock Alerts - Newser
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Why is C4 Therapeutics Inc. stock going downDay Trading 5x Gain Picks - mustnews.co.kr
Akamis Bio Announces the Appointment of Andrew Hirsch to the Company’s Board of Directors - Business Wire
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Why C4 Therapeutics Inc. stock attracts strong analyst attentionStock Forecast Tools for Retail Traders - Newser
C 4 Therapeutics Inc (CCCC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.98%
8.06%
자본화:
|
볼륨(24시간):